RIDGWAY OSTEOGENIC SARCOMA. A PROMISING LABORATORY MODEL FOR SPECIAL THERAPEUTIC TRIALS AGAINST AN ADVANCED-STAGED, DRUG-SENSITIVE ANIMAL TUMOR SYSTEM = OSTEOSARCOME DE RIDGWAY. UN MODELE EXPERIMENTAL PROMETTEUR POUR DES ESSAIS THERAPEUTIQUES PARTICULIERS SUR UN SYSTEME TUMORAL ANIMAL SENSIBLE AU MEDICAMENT, A UN STADE AVANCELASTER WR JR.1975; CANCER CHEMOTHERAPY REP., 2; U.S.A.; DA. 1975; VOL. 5; NO 1; PP. 151-168; BIBL. 8 REF.; (SCREENERS CONF. PROC.; SILVER SPRING, MD.; 1975)Conference Paper

EXPERIMENTAL STUDIES OF THE CONTITUMOR ACTIVITY OF AMYGDALIN MF(NSC-15780) ALONE AND IN COMBINATION WITH BETA -GLUCOSIDASE (NSC-128056).LASTER WR JR; SCHABEL FM JR.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 5; PP. 951-965; BIBL. 3 REF.Article

EVALUATION OF WHOLE-BODY HYPERTHERMIA AS AN ADJUNCT TO CHEMOTHERAPY IN MURINE TUMORSROSE WC; VERAS GH; LASTER WR JR et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 8; PP. 1311-1325; BIBL. 31 REF.Article

STUDIES WITH 8-AZAINOSINE, A CYTOTOXIC NUCLEOSIDE WITH ANTITUMOR ACTIVITYBENNETT LL JR; VAIL MH; ALLAN PW et al.1973; CANCER RES.; U.S.A.; DA. 1973; VOL. 33; NO 3; PP. 465-471; BIBL. 24 REF.Serial Issue

CHRONOCHEMOTHERAPY OF L1210 LEUKEMIC MICE WITH CYTOSINE ARABINOSIDE OR CYCLOPHOSPHAMIDEROSE WC; TRADER MW; LASTER WR JR et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 9; PP. 1337-1349; BIBL. 20 REF.Article

COMPARATIVE ANTITUMOR ACTIVITY OF ACTINOMYCIN ANALOGS IN MICE BEARING RIDGWAY OSTEOGENIC SARCOMA OR P388 LEUKEMIA.ROSE WC; TRADER MW; LASTER WR JR et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 5; PP. 779-789; BIBL. 16 REF.Article

THERAPEUTIC POTENTIATION OF NITROSOUREAS USING CHLORPROMAZINE AND CAFFEINE IN THE TREATMENT OF MURINE TUMORSROSE WC; TRADER MW; DYKES DJ et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 12; PP. 2085-2093; BIBL. 19 REF.Article

ASIC AND THERAPEUTIC TRIAL RESULTS OBTAINED IN THE SPONTANEOUS AK LEUKEMIA (LYMPHOMA) MODEL-END OF 1971SKIPPER HE; SCHABEL FM JR; TRADER MW et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 3; PP. 273-314 (41P.); BIBL. 53REF.Serial Issue

RESPONSE OF TRANSPLANTABLE TUMORS OF MICE TO ANTHRACENEDIONE DERIVATIVES ALONE AND IN COMBINATION WITH CLINICALLY USEFUL AGENTSCORBETT TH; ROBERTS BJ; TRADER RW et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 5; PP. 1187-1200; BIBL. 17 REF.Article

INHIBITION OF SOLID TUMORS BY NITROSOUREAS. I. LEWIS LUNG CARCINOMA.MONTGOMERY JA; MCCALEB GS; JOHNSTON TP et al.1977; J. MEDICIN. CHEM.; U.S.A.; DA. 1977; VOL. 20; NO 2; PP. 291-295; BIBL. 13 REF.Article

QUANTITATIVE EVALUATION OF ANTICANCER AGENT ACTIVITY IN EXPERIMENTAL ANIMALS.SCHABEL FM JR; GRISWOLD DP JR; LASTER WR JR et al.1977; PHARMACOL. AND THERAPEUT., A; G.B.; DA. 1977; VOL. 1; NO 4; PP. 411-435; BIBL. 1 P. 1/2Article

PRECLINICAL EVALUATION OF ANTICANCER DRUGS. I: TESTING THERAPEUTIC HYPOTHESES IN MICE AND MAN: OBSERVATIONS ON THE THERAPEUTIC ACTIVITY AGAINST ADVANCED SOLID TUMORS OF MICE TREATED WITH ANTICANCER DRUGS THAT HAVE DEMONSTRATED OR POTENTIAL CLINICAL UTILITY FOR TREATMENT OF ADVANCED SOLID TUMORS OF MASSSCHABEL FM JR; GRISWOLD DP JR; CORBETT TH et al.1979; METHODS CANCER RES.; USA; DA. 1979; VOL. 17; PP. 3-51; BIBL. 2 P.Article